tiprankstipranks
Advertisement
Advertisement

ARMP Stock Latest News

Armata Pharmaceuticals granted $2.5M additional non-dilutive award funding
The FlyArmata Pharmaceuticals granted $2.5M additional non-dilutive award funding
11d ago
ARMP
Armata gains new DoD funding for AP-SA02 advancement
PremiumCompany Announcements
Armata gains new DoD funding for AP-SA02 advancement
11d ago
8K
ARMP
Armata Shareholders Approve Directors, Executive Pay and Auditor
PremiumCompany Announcements
Armata Shareholders Approve Directors, Executive Pay and Auditor
18d ago
8K
ARMP
Analyst Reiterates Buy on Armata, Maintaining $20 Price Target Ahead of Pivotal Phase 3 AP-SA02 Trial
PremiumRatings
Analyst Reiterates Buy on Armata, Maintaining $20 Price Target Ahead of Pivotal Phase 3 AP-SA02 Trial
1M ago
ARMP
Armata Secures New Loan Amid Wider Quarterly Loss
PremiumCompany Announcements
Armata Secures New Loan Amid Wider Quarterly Loss
2M ago
8K
ARMP
Armata Pharmaceuticals reports Q1 EPS ($3.16) vs. (20c) last year
PremiumThe FlyArmata Pharmaceuticals reports Q1 EPS ($3.16) vs. (20c) last year
2M ago
ARMP
Armata Pharmaceuticals secures FDA Fast Track Designation for AP-SA02
Premium
The Fly
Armata Pharmaceuticals secures FDA Fast Track Designation for AP-SA02
2M ago
ARMP
Armata Gains FDA Fast Track for AP-SA02 Therapy
Premium
Company Announcements
Armata Gains FDA Fast Track for AP-SA02 Therapy
2M ago
8K
ARMP
Armata Pharmaceuticals Adds Pfizer Executive to Board of Directors
PremiumCompany Announcements
Armata Pharmaceuticals Adds Pfizer Executive to Board of Directors
2M ago
8K
ARMP
Armata Pharmaceuticals price target raised to $20 from $15 at JonesResearch
PremiumThe Fly
Armata Pharmaceuticals price target raised to $20 from $15 at JonesResearch
3M ago
ARMP
Armata Pharmaceuticals Sets Timeline for 2026 Annual Meeting
PremiumCompany Announcements
Armata Pharmaceuticals Sets Timeline for 2026 Annual Meeting
3M ago
8K
ARMP
Armata Pharmaceuticals reports Q4 EPS ($3.42) vs. (23c) last year
PremiumThe Fly
Armata Pharmaceuticals reports Q4 EPS ($3.42) vs. (23c) last year
3M ago
ARMP
Armata Highlights AP-SA02 Progress Amid Earnings Release Delay
PremiumCompany AnnouncementsArmata Highlights AP-SA02 Progress Amid Earnings Release Delay
4M ago
8K
ARMP
Armata Pharmaceuticals delays announcement of Q4, FY25 results
Premium
The Fly
Armata Pharmaceuticals delays announcement of Q4, FY25 results
4M ago
ARMP
ARMP Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
ARMP Earnings Report this Week: Is It a Buy, Ahead of Earnings?
4M ago
ARMP
Armata price target raised to $15 from $9 at H.C. Wainwright
PremiumThe Fly
Armata price target raised to $15 from $9 at H.C. Wainwright
4M ago
ARMP
Armata Gains QIDP Status for AP-SA02 Bacteremia Therapy
PremiumCompany Announcements
Armata Gains QIDP Status for AP-SA02 Bacteremia Therapy
4M ago
8K
ARMP
Armata Pharmaceuticals receives FDA QIDP designation for AP-SA02
PremiumThe Fly
Armata Pharmaceuticals receives FDA QIDP designation for AP-SA02
4M ago
ARMP
Armata Extends Innoviva Credit, Warrants and Voting Pact
PremiumCompany Announcements
Armata Extends Innoviva Credit, Warrants and Voting Pact
5M ago
8K
ARMP
Armata Pharmaceuticals: FDA-Endorsed Phase 3 Path and Potential QIDP Upside Support Buy Rating on AP-SA02
PremiumRatingsArmata Pharmaceuticals: FDA-Endorsed Phase 3 Path and Potential QIDP Upside Support Buy Rating on AP-SA02
6M ago
ARMP
Armata Wins FDA Support to Advance Bacteriophage to Phase 3
Premium
Company Announcements
Armata Wins FDA Support to Advance Bacteriophage to Phase 3
6M ago
8K
ARMP
Armata Pharmaceuticals announces End-of-Phase 2 meeting with FDA
Premium
The Fly
Armata Pharmaceuticals announces End-of-Phase 2 meeting with FDA
6M ago
ARMP

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >